Keene J A, Forman J
J Exp Med. 1982 Mar 1;155(3):768-82. doi: 10.1084/jem.155.3.768.
B6.T1a(a) (Qa-1(a)) mice that are primed in vivo and restimulated in vitro with Qa-1 congenic spleen cells from B6 (Qa-1(b)) animals are unable to generate anti-Qa-1(b) cytotoxic T lymphocytes (CTL). This nonresponsive pattern was observed regardless of the route of immunization or the time of testing in vitro. Although B6.T1a(a) mice are nonresponders to Qa-1(b) when presented on B6 cells, these mice can generate anti-Qa-1(b) CTL when primed in vivo with Qa-1 and H-Y alloantigens (females primed with B6 male cells) or Qa-1 and minor-H- alloantigens (primed with sex-matched A.BY cells). Therefore, the inability to generate anti-Qa-1(b) CTL is due to a lack of helper or accessory antigens on B6 immunizing cells obligatory during in vivo priming, rather than an absence of anti-Qa-1(b) CTL precursors (CTL-P). Demonstration that the additional determinants required during in vivo priming actually function as carrier or helper determinants was shown by the requirement for linked recognition of Qa-1 and the helper determinants (H-Y) in vivo, and the fact that H-Y was not present on susceptible target ceils. Animals primed in vivo with H-Y only could not generate anti-Qa-1 CTL activity when challenged in vitro with both Qa-1 and H-Y, indicating that recognition of the helper determinant causes in vivo priming of CTL-P rather than generating helper activity that might activate unprimed CTL-P in vitro. Whereas unprimed peripheral CTL-P require the presence of both Qa-1 (CTL) and H-Y (helper) determinants for successful in vivo priming, helper determinants were not required in vitro because primed CTL-P from B6.T1a(a) mice could be driven to CTL in vitro using sex-matched B6 stimulator cells. The generation of anti-Qa-1(b) CTL is under immune response (Ir) gene control because F(1) mice, obtained by crossing responder A/J with nonresponder B6.T1a(a) animals, generated CTL to the Qa-1(b) alloantigen when presented on B6 spleen cells. Progeny testing of backcross mice further demonstrated that the Ir gene(s) is linked to the H-2 complex. These data indicate that an H-2-linked Ir gene controls the recognition of helper determinants required for CTL priming in vivo. These helper determinants can be distinguished from CTL determinants and both must be recognized together for successful priming of CTL-P.
用来自B6(Qa-1(b))动物的Qa-1同基因脾细胞在体内进行致敏并在体外进行再刺激的B6.T1a(a)(Qa-1(a))小鼠,无法产生抗Qa-1(b)细胞毒性T淋巴细胞(CTL)。无论免疫途径或体外检测时间如何,均观察到这种无反应模式。尽管B6.T1a(a)小鼠在B6细胞上呈现Qa-1(b)时对其无反应,但当用Qa-1和H-Y同种异体抗原(用B6雄性细胞致敏的雌性小鼠)或Qa-1和次要组织相容性抗原(用性别匹配的A.BY细胞致敏)在体内进行致敏时,这些小鼠可以产生抗Qa-1(b) CTL。因此,无法产生抗Qa-1(b) CTL是由于在体内致敏过程中B6免疫细胞上缺乏辅助或辅助抗原,而不是由于缺乏抗Qa-1(b) CTL前体(CTL-P)。体内致敏过程中所需的额外决定簇实际上作为载体或辅助决定簇起作用,这一点通过体内对Qa-1和辅助决定簇(H-Y)的连锁识别需求以及易感靶细胞上不存在H-Y这一事实得以证明。仅用H-Y在体内进行致敏的动物,在体外同时用Qa-1和H-Y进行攻击时,无法产生抗Qa-1 CTL活性,这表明对辅助决定簇的识别导致CTL-P在体内致敏,而不是产生可能在体外激活未致敏CTL-P的辅助活性。未致敏的外周CTL-P在体内成功致敏需要同时存在Qa-1(CTL)和H-Y(辅助)决定簇,而在体外则不需要辅助决定簇,因为来自B6.T1a(a)小鼠的致敏CTL-P可以用性别匹配的B6刺激细胞在体外诱导为CTL。抗Qa-1(b) CTL的产生受免疫反应(Ir)基因控制,因为通过将反应性A/J与无反应性B6.T1a(a)动物杂交获得的F(1)小鼠,当在B6脾细胞上呈现Qa-1(b)同种异体抗原时,会产生CTL。回交小鼠的子代检测进一步证明Ir基因与H-2复合体连锁。这些数据表明,一个与H-2连锁的Ir基因控制着体内CTL致敏所需的辅助决定簇的识别。这些辅助决定簇可以与CTL决定簇区分开来,并且两者必须同时被识别才能成功地使CTL-P致敏。